Skip to main content
SpringerLink
Log in

Efficacy of Polyvalent Bacteriophage P-27/HP to Control Multidrug Resistant Staphylococcus aureus Associated with Human Infections

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Emergence of multidrug resistant strains has created serious problem for safe eradication of Staphylococcus aureus infections. Therefore, there is an urgent need to develop novel antibacterial agents to control this pathogen. Bacteriophages kill bacteria irrespective of their antibiotic sensitivity and thus they can be used as potent prophylactic/therapeutic agent to treat such infections. Here, we report isolation of broad host range anti-staphylococcal lytic bacteriophage P-27/HP from sewage water. This phage was able to inhibit 17 of 28 (60%) human disease associated S. aureus isolates. In vitro studies revealed its strong lytic efficacy to diminish S. aureus 27/HP population (c.f.u.) by more than 5.0 logs (P < 0.0001) (equivalent to 99.99%) in 3 h at 0.01 MOI. In vivo lytic efficacy analysis showed that a single subcutaneous injection of phage P-27/HP (107 p.f.u.) was sufficient to protect S. aureus 27/HP infected (5 × 108 c.f.u.) mice from bacteremia and subsequent death. A considerable decline of more than 6 logs (99.9%) in splenic S. aureus 27/HP c.f.u. count was noted at the 3 days of phage treatment. In conclusion, our results suggest that phage P-27/HP is polyvalent in nature and has high-lytic potential towards S. aureus, thus, a therapy employing this phage would be efficacious to control S. aureus infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adams MH (1959) Bacteriophages. Interscience, New York

    Google Scholar 

  2. Anupurba S, Sen MR, Nath G et al (2003) Prevalence of methicillin resistance Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21(1):49–51

    CAS  PubMed  Google Scholar 

  3. Capparelli R, Parlato M, Borriello G et al (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51:2765–2773. doi:10.1128/AAC.01513-06

    Article  CAS  PubMed  Google Scholar 

  4. Casey AL, Lambert PA, Elliott TSJ (2007) Staphylococci. Int J Antimicrob Agents 29(3):S23–S32. doi:10.1016/S0924-8579(07)72175-1

    Article  CAS  PubMed  Google Scholar 

  5. Chamber HF (2005) Community-associated MRSA—resistance and virulence converge. New Engl J Med 352:1485–1487

    Article  Google Scholar 

  6. Cowan ST, Steel KJ (1975) Manual for identification of medical bacteria. Cambridge University press, London

    Google Scholar 

  7. El-Jakee J, Nagwa AS, Bakry M et al (2008) Characteristics of Staphylococcus aureus strains isolated from human and animal sources. Am Eurasian J Agric Environ Sci 4(2):221–229

    Google Scholar 

  8. Eisenstark A (1967) Bacteriophage techniques. In: Maramorsch K, Koprowski H (eds) Methods in virology 1. Academic press, New York, pp 449–524

    Google Scholar 

  9. Gorski A, Miedzybrodzki R, Borysowski J et al (2009) Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs 10(8):766–774

    CAS  PubMed  Google Scholar 

  10. Jernigan JA, Farr BM (1993) Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 119:304–311

    CAS  PubMed  Google Scholar 

  11. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273. doi:10.1172/JCI200318535

    CAS  PubMed  Google Scholar 

  12. Matsuzaki S, Yasuda M, Nishikawa H et al (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 187:613–624. doi:10.1086/374001

    Article  CAS  PubMed  Google Scholar 

  13. Merabishvili M, Pirnay JP, Verbeken G et al (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4(3):e4944. doi:10.1371/journal.pone.0004944

  14. National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A6, 7th edn. NCCLS, Wayne, PA

    Google Scholar 

  15. O’Flaherty S, Ross RP, Meaney W et al (2005) Potential of the polyvalent anti-Staphylococcus bacteriophage K for the control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71:1836–1842. doi:10.1128/AEM.71.4.1836-1842.2005

    Article  PubMed  Google Scholar 

  16. O’Flaherty S, Ross RP, Coffey A (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33:801–819. doi:10.1111/j.1574-6976.2009.00176.x

    Article  PubMed  Google Scholar 

  17. Service RF (2004) Orphan drugs of the future? Science 303:1798. doi:10.1126/science.303.5665.1798

    Article  PubMed  Google Scholar 

  18. Sulakvelidze A, Alavidze Z, Morris JG Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649–659. doi:10.1128/AAC.45.3.649-659.2001

    Article  CAS  PubMed  Google Scholar 

  19. Synnott AJ, Kuang Y, Kurimoto M et al (2009) Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl Environ Microbiol 4483–4490. doi:10.1128/AEM.02641-08

  20. Wenzel RP, Bearman G, Edmond MB (2007) Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents 30:210–212. doi:10.1016/j.ijantimicag.2007.04.003

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Biological Standardization, Indian Veterinary Research Institute, Izatnagar, 243122, Uttar Pradesh, India

    Ragini Gupta

  2. Department of Animal Science, M. J. P. Rohilkhand University, Bareilly, 243006, Uttar Pradesh, India

    Ragini Gupta & Yogendra Prasad

  3. Department of Chemical Engineering, Indian Institute of Technology Kanpur, Kanpur, 208016, Uttar Pradesh, India

    Ragini Gupta

Authors
  1. Ragini Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yogendra Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ragini Gupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, R., Prasad, Y. Efficacy of Polyvalent Bacteriophage P-27/HP to Control Multidrug Resistant Staphylococcus aureus Associated with Human Infections. Curr Microbiol 62, 255–260 (2011). https://doi.org/10.1007/s00284-010-9699-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00284-010-9699-x

Keywords

Search

Navigation